ViaNautis, formerly known as SomaServe, was founded in 2018 as a spin-off from UCL under the leadership of CEO and serial entrepreneur, Dr Francesca Crawford. The company’s core mission is to exploit the unique capabilities of the revolutionary polyNaut® technology.

PolyNaut® is a versatile nano-engineered polymer technology designed for targeted intracellular delivery. This innovative technology enables polymer nanoparticles to deliver a wide range of payloads from small molecules to genetic materials creating ‘a bionic nanoparticle.’ The highly adaptable polymer structure of polyNaut® can be formulated to encapsulate a wide array of genetic cargoes, with sizes exceeding current standards for viral and non-viral delivery. Notably, it enhances the therapeutic efficacy of encapsulated molecules through direct delivery to the cell cytoplasm, facilitated by GOTO® technology for intracellular shuttling.

PolyNaut® is set apart from conventional non-viral delivery technologies through its remarkable ability to target specific cells and penetrate biological barriers, including the challenging blood-brain barrier. PolyNaut® nanoparticles, when functionalised for CNS delivery through transcytosis, exhibit exceptional brain uptake.

Deploying its state-of-the-art polyNaut® platform, ViaNautis is at the forefront of pioneering new therapies for CNS diseases and cystic fibrosis. The company is actively building an internal pipeline and collaborating with leading pharmaceutical and biotech companies to unlock the potential of promising genetic molecules as well as new therapeutic platforms.

Therapeutics

Pharmaceutical

Life Sciences

Biotechnology

Vianautis

Vianautis' headquarters in Cambridge, United Kingdom

Adi Hoess

The Research and Development team at ViaNautis focuses on advancing the polyNaut® technology by exploring its applications in targeted intracellular delivery. This involves designing and optimizing polymer nanoparticles for efficient delivery of therapeutic molecules, conducting preclinical studies, and developing innovative solutions for CNS diseases and cystic fibrosis. The team collaborates closely with pharmaceutical and biotech partners to expand the therapeutic potential of genetic molecules and new treatment platforms.

Research and Development

This department specializes in the development and optimization of formulation processes and products.

Formulations Department

This department focuses on advancing knowledge and innovation through scientific investigations and studies.

Scientific Research

The Leadership Team at ViaNautis is responsible for steering the company towards its mission of leveraging the revolutionary polyNaut® technology for advanced therapeutic solutions. This team leads strategic decision-making, oversees business operations, fosters scientific and technological innovation, and ensures successful collaborations with pharmaceutical and biotech partners. Through their collective expertise, they guide the company in pioneering new therapies for CNS diseases and cystic fibrosis while building a robust internal pipeline and expanding the potential of polyNaut® technology.

Leadership Team

This department oversees the planning and execution of operational activities to ensure efficiency and productivity across projects.

Operations Management

This department conducts research and analysis to support various organizational initiatives.

Vianautis

Org chart

Teams

Research and Development

Formulations Department

Scientific Research

Leadership Team

Operations Management

Research Department

Offices

Vianautis

Org chart

Teams

Research and Development

Formulations Department

Scientific Research

Leadership Team

Operations Management

Research Department

Offices

Related companies